Young bone marrow transplants show promise in reversing Alzheimer’s symptoms in mice

FHS
June 4, 2024
4:39 am

Researchers found that young bone marrow transplants rejuvenate aging immune cells, reducing Alzheimer’s symptoms in mice models, suggesting a potential therapeutic approach for the disease.

CAH Drug Under Review; Gender-Affirming Surgery in Kids; CGMs for Non-Diabetics

The FDA accepted Neurocrine Bioscience’s new drug applications with priority review for crinecerfont, an investigational treatment for pediatric and adult patients with classic congenital adrenal

July 2, 2024

Scientists discover new way to defeat invisible cancer cells

Modern immunotherapies boost the body’s own defenses against cancer. They activate killer T cells of the immune system that can specifically recognize and destroy cancer

June 23, 2023

Broken String Biosciences appoints Laurence Reid and Brad Crutchfield to its Board of Directors

Broken String Biosciences enhances its leadership team with Laurence Reid and Brad Crutchfield, aiming to revolutionize cell and gene therapy development.

September 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.